Gene Therapy in Diabetes

Overview

Journal Self Nonself

Specialty Allergy & Immunology

Date 2011 Apr 14

PMID 21487475

Citations 11

Authors

Mary S Wong

Wayne J Hawthorne

Nicholas Manolios

Affiliations

Soon will be listed here.

Abstract

Type 1 diabetes (T1D) is a chronic autoimmune disease, whereby auto-reactive cytotoxic T cells target and destroy insulin-secreting β-cells in pancreatic islets leading to insulin deficiency and subsequent hyperglycemia. These individuals require multiple daily insulin injections every day of their life without which they will develop life-threatening diabetic ketoacidosis (DKA) and die. Gene therapy by viral vector and non-viral transduction may be useful techniques to treat T1D as it can be applied from many different angles; such as the suppression of autoreactive T cells to prevent islet destruction (prophylactic) or the replacement of the insulin gene (post-disease). The need for a better method for providing euglycemia arose from insufficient numbers of cadaver islets for transplantation and the immunosuppression required post-transplant. Ectopic expression of insulin or islet modification have been examined, but not perfected. This review examines the various gene transfer methods, gene therapy techniques used to date and promising novel techniques for the maintenance of euglycemia in the treatment of T1D.

Citing Articles

Nanomedicine in the Treatment of Diabetes.

Andreadi A, Lodeserto P, Todaro F, Meloni M, Romano M, Minasi A Int J Mol Sci. 2024; 25(13).

PMID: 39000136 PMC: 11241380. DOI: 10.3390/ijms25137028.

Advances and challenges of the cell-based therapies among diabetic patients.

Raoufinia R, Rahimi H, Saburi E, Moghbeli M J Transl Med. 2024; 22(1):435.

PMID: 38720379 PMC: 11077715. DOI: 10.1186/s12967-024-05226-3.

A Mini-Review of Current Treatment Approaches and Gene Therapy as Potential Interventions for Diabetes Mellitus Types 1.

Dezashibi H, Shabani A Adv Biomed Res. 2023; 12:219.

PMID: 38073738 PMC: 10699226. DOI: 10.4103/abr.abr_201_23.

Novel targets for potential therapeutic use in Diabetes mellitus.

Dhankhar S, Chauhan S, Mehta D, Nitika , Saini K, Saini M Diabetol Metab Syndr. 2023; 15(1):17.

PMID: 36782201 PMC: 9926720. DOI: 10.1186/s13098-023-00983-5.

PDX1 is the cornerstone of pancreatic β-cell functions and identity.

Ebrahim N, Shakirova K, Dashinimaev E Front Mol Biosci. 2023; 9:1091757.

PMID: 36589234 PMC: 9798421. DOI: 10.3389/fmolb.2022.1091757.

References

Sigalla J, David A, Anegon I, Fiche M, Huvelin J, Boeffard F . Adenovirus-mediated gene transfer into isolated mouse adult pancreatic islets: normal beta-cell function despite induction of an anti-adenovirus immune response. Hum Gene Ther. 1997; 8(13):1625-34. DOI: 10.1089/hum.1997.8.13-1625. View

McDaniel M, Kwon G, Hill J, Marshall C, Corbett J . Cytokines and nitric oxide in islet inflammation and diabetes. Proc Soc Exp Biol Med. 1996; 211(1):24-32. DOI: 10.3181/00379727-211-43950d. View

Meagher C, Arreaza G, Peters A, Strathdee C, Gilbert P, Mi Q . CCL4 protects from type 1 diabetes by altering islet beta-cell-targeted inflammatory responses. Diabetes. 2007; 56(3):809-17. DOI: 10.2337/db06-0619. View

Gale E, Gillespie K . Diabetes and gender. Diabetologia. 2001; 44(1):3-15. DOI: 10.1007/s001250051573. View

Dabelea D, Bell R, DAgostino Jr R, Imperatore G, Johansen J, Linder B . Incidence of diabetes in youth in the United States. JAMA. 2007; 297(24):2716-24. DOI: 10.1001/jama.297.24.2716. View

Lernmark A, Barmeier H, Dube S, Hagopian W, Karlsen A, Markholst H . Molecular analysis of the pathogenesis of beta-cell destruction in insulin-dependent diabetes mellitus. West J Med. 1990; 153(5):499-502. PMC: 1002598. View

Amon M, Ali M, Bender V, Chan Y, Toth I, Manolios N . Lipidation and glycosylation of a T cell antigen receptor (TCR) transmembrane hydrophobic peptide dramatically enhances in vitro and in vivo function. Biochim Biophys Acta. 2006; 1763(8):879-88. DOI: 10.1016/j.bbamcr.2006.04.013. View

Qiao Q, Osterholm A, He B, Pitkaniemi J, Cordell H, Sarti C . A genome-wide scan for type 1 diabetes susceptibility genes in nuclear families with multiple affected siblings in Finland. BMC Genet. 2007; 8:84. PMC: 2225422. DOI: 10.1186/1471-2156-8-84. View

Elamin A, Omer M, Zein K, Tuvemo T . Epidemiology of childhood type I diabetes in Sudan, 1987-1990. Diabetes Care. 1992; 15(11):1556-9. DOI: 10.2337/diacare.15.11.1556. View

10.

Chong J, Craig M, Cameron F, Clarke C, Rodda C, Donath S . Marked increase in type 1 diabetes mellitus incidence in children aged 0-14 yr in Victoria, Australia, from 1999 to 2002. Pediatr Diabetes. 2007; 8(2):67-73. DOI: 10.1111/j.1399-5448.2007.00229.x. View

11.

Harris M, Robbins D . Prevalence of adult-onset IDDM in the U.S. population. Diabetes Care. 1994; 17(11):1337-40. DOI: 10.2337/diacare.17.11.1337. View

12.

Klein R . Diabetic retinopathy. Annu Rev Public Health. 1996; 17:137-58. DOI: 10.1146/annurev.pu.17.050196.001033. View

13.

Durruty P, Ruiz F, GARCIA DE LOS RIOS M . Age at diagnosis and seasonal variation in the onset of insulin-dependent diabetes in Chile (Southern hemisphere). Diabetologia. 1979; 17(6):357-60. DOI: 10.1007/BF01236269. View

14.

Scott C, Smith J, Cradock M, Pihoker C . Characteristics of youth-onset noninsulin-dependent diabetes mellitus and insulin-dependent diabetes mellitus at diagnosis. Pediatrics. 1997; 100(1):84-91. DOI: 10.1542/peds.100.1.84. View

15.

Shternhall-Ron K, Quintana F, Perl S, Meivar-Levy I, Barshack I, Cohen I . Ectopic PDX-1 expression in liver ameliorates type 1 diabetes. J Autoimmun. 2007; 28(2-3):134-42. DOI: 10.1016/j.jaut.2007.02.010. View

16.

Quinn M, Fleischman A, Rosner B, Nigrin D, Wolfsdorf J . Characteristics at diagnosis of type 1 diabetes in children younger than 6 years. J Pediatr. 2006; 148(3):366-71. DOI: 10.1016/j.jpeds.2005.10.029. View

17.

Bregenholt S, Wang M, Wolfe T, Hughes A, Baerentzen L, Dyrberg T . The cholera toxin B subunit is a mucosal adjuvant for oral tolerance induction in type 1 diabetes. Scand J Immunol. 2003; 57(5):432-8. DOI: 10.1046/j.1365-3083.2003.01248.x. View

18.

Huynh N, Ffrench R, Boadle R, Manolios N . Transmembrane T-cell receptor peptides inhibit B- and natural killer-cell function. Immunology. 2003; 108(4):458-64. PMC: 1782915. DOI: 10.1046/j.1365-2567.2003.01614.x. View

19.

Panakanti R, Mahato R . Bipartite adenoviral vector encoding hHGF and hIL-1Ra for improved human islet transplantation. Pharm Res. 2008; 26(3):587-96. PMC: 2933074. DOI: 10.1007/s11095-008-9777-y. View

20.

Arnush M, Heitmeier M, Scarim A, Marino M, Manning P, Corbett J . IL-1 produced and released endogenously within human islets inhibits beta cell function. J Clin Invest. 1998; 102(3):516-26. PMC: 508912. DOI: 10.1172/JCI844. View